Bio

Yash has more than 15 years of operating and investing experience in healthcare, life science and industrial markets working with both private equity and public companies. Before joining Essex Bay, Yash was President at Analogic where he led their MRI and robotics business ($150 million revenue) and Executive Vice President at Harvard Biosciences where he led the cellular, molecular and physiology business ($80 million revenue). At Analogic and Harvard Bioscience he drove step change revenue growth and profitability acceleration. He also led acquisition and integration of multiple successful targets at Analogic. Earlier, Yash worked in strategy consulting at Booz Allen. He has a B.S. in chemical engineering from the Indian Institute of Technology, Bombay and an MBA from Haas School of Business, University of California, Berkeley.